Overview

Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes Mellitus

Status:
Unknown status

Trial end date:
2011-02-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate the success rate of a switch from insulin therapy to a metformin & saxagliptin combination in patients with type 2 diabetes mellitus.

Phase:

Phase 4

Details

Lead Sponsor:

ikfe-CRO GmbH

Collaborators:

AstraZeneca
IKFE Institute for Clinical Research and Development

Treatments:

Insulin
Insulin, Globin Zinc
Metformin
Saxagliptin